Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
Ourotech Limited (United Kingdom)
Homepage:
pearbio.com
Alternate names:
Ourotech Limited,
Pear Bio
ROR:
02cfb4s15
OpenAlex ID:
I4405267358
Developing a functional precision medicine assay to predict pathological complete response in patients with triple-negative breast cancer: Interim results from the PEAR-TNBC Trial
2024
·
Peter Hall
, Matthew Williams
, et al.
·
medRxiv
·
2
Integrating Functional Precision Medicine With Patient and Public Engagement (ppie) in the Pear-glio Trial for Brain Tumour Treatment Optimisation
2025
·
Miss Lillie Pakzad-Shahabi
, Ethan Williams
, et al.
·
Neuro-Oncology
·
1
PDF
Clinical validation of image-based AI predictive biomarkers for precision neoadjuvant triple-negative breast cancer treatment (PEAR-TNBC).
2024
·
Matthew Williams
, Eleonora Peerani
, et al.
·
Journal of Clinical Oncology
·
1
Exploring Personalised Glioblastoma Therapies Through Functional Precision Medicine: Early Data From Pear-glio
2025
·
Matt Williams
, Eleonora Peerani
, et al.
·
Neuro-Oncology
PDF
Transforming kidney cancer treatment through AI-enabled functional precision medicine: The PEAR-TREE2 trial.
2025
·
Matthew Williams
, Ekaterini Boleti
, et al.
·
Journal of Clinical Oncology
PEAR-GLIO: Clinical evaluation of an AI-driven functional precision medicine platform for therapeutic efficacy in gliomas.
2025
·
Matthew Williams
, Eleonora Peerani
, et al.
·
Journal of Clinical Oncology
PDF
Abstract 3011: Novel CDK12 inhibitors with preclinical anti-tumor activity and best-in-class profile on HER2 low breast cancer patient samples
2025
·
Chandan Seth Nanda
, Maria New
, et al.
·
Cancer Research
Abstract 3917: A functional precision medicine assay for immunotherapy and combination therapy testing in liver and pancreatic cancers (PEAR-PAL)
2025
·
Eleonora Peerani
, Farah Sangkolah
, et al.
·
Cancer Research
Abstract 4724: Evaluating immunotherapy and combination therapy efficacy in kidney cancer using a multicellular 3D immune-microtumor model
2025
·
Eleonora Peerani
, Keqian Nan
, et al.
·
Cancer Research
Abstract B021: Optimizing combination immunotherapy regimens in kidney cancer using ex-vivo multicellular 3D immune-microtumors and multiplex immunoassays
2025
·
Roseanna Hare
, Eleonora Peerani
, et al.
·
Cancer Immunology Research
18 Multivariate analysis of ex vivo kidney 3D immune-microtumors for functional precision medicine: development, translation and application of a novel platform to predict treatment response
2024
·
Jay Kearney
, Keqian Nan
, et al.
·
Journal for ImmunoTherapy of Cancer
Abstract 6767: Multivariate analysis of ex vivo kidney 3D immune-microtumors for functional precision medicine
2024
·
Eleonora Peerani
, Keqian Nan
, et al.
·
Cancer Research
Development of a kidney cancer ex vivo tumor model and image-based artificial intelligence tool for precision immunotherapy and combination therapy testing.
2023
·
Eleonora Peerani
, Jay Kearney
, et al.
·
Journal of Clinical Oncology
PDF
Genome editing and regulation of transcription and translational using CRISPR-Cas9 system
2023
·
Chandan Seth Nanda
·
Elsevier eBooks
Show more works
View as search
Works count:
14
Citation count:
46
Year
Topic
Type
